StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Other Cardiovascular sub-franchise by Quarter

Other Cardiovascular sub-franchise — Worldwide sales ($M) ($M)

QuarterlyAnnual

Johnson & Johnson Other Cardiovascular sub-franchise: $81M in Q3 2026, down 14.7% from a year earlier.

Latest, Q3 2026
81
Period ended Sep 30, 2026
Change on a year earlier
-14.7%
95 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
14
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-21) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Cardiovascular sub-franchise — Worldwide sales ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202681-14.7%Form 10-Q (filed 2026-10-21) ↗
Q2 2026Jun 28, 202698-5.8%Form 10-Q (filed 2026-07-23) ↗
Q1 2026Mar 29, 202694-8.7%Form 10-Q (filed 2026-04-22) ↗
Q4 2025Dec 28, 202595-4.0%Form 10-K (filed 2026-02-11) ↗
Q3 2025Sep 28, 202595-1.0%Form 10-Q (filed 2026-10-21) ↗
Q2 2025Jun 29, 2025104+11.8%Form 10-Q (filed 2026-07-23) ↗
Q1 2025Mar 30, 2025103+12.0%Form 10-Q (filed 2026-04-22) ↗
Q4 2024Dec 29, 202499+11.2%Form 10-K (filed 2026-02-11) ↗
Q3 2024Sep 29, 202496+10.3%Form 10-Q (filed 2025-10-22) ↗
Q2 2024Jun 30, 2024930.0%Form 10-Q (filed 2025-07-24) ↗
Q1 2024Mar 31, 202492+5.7%Form 10-Q (filed 2025-04-23) ↗
Q4 2023Dec 31, 202389+20.3%Form 10-K (filed 2026-02-11) ↗
Q3 2023Oct 1, 2023870.0%Form 10-Q (filed 2024-10-23) ↗
Q2 2023Jul 2, 202393+14.8%Form 10-Q (filed 2024-07-25) ↗
Q1 2023Apr 2, 202387-3.3%Form 10-Q (filed 2024-05-01) ↗
Q4 2022Jan 1, 202374–Form 10-K (filed 2025-02-13) ↗

Breakdown

What makes up other Cardiovascular sub-franchise

Cite this data

StockData. (2026). Johnson & Johnson Other Cardiovascular sub-franchise ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-other-cv

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.